Web Results

www.law360.com/articles/801453/chelsea-therapeutics-settles-investor-class-action-for-5-5m

May 27, 2016 ... Chelsea Therapeutics International Inc. has agreed to pay $5.5 million in cash to settle an ... The case is Roman Zak and Cameron McIntyre v.

www.prnewswire.com/news-releases/proposed-settlement-reached-in-class-action-involving-chelsea-therapeutics-international-ltd-chtp-common-stock-300289723.html

Jun 28, 2016 ... Chelsea Therapeutics International, Ltd., et al., No ... Notice") and a copy of the Proof of Claim and Release form by writing to McIntyre v.

securities.stanford.edu/filings-documents/1052/CTIL00_01/2014530_f01c_14CV00687.pdf

Jul 1, 2014 ... similarly situated holders of Chelsea Therapeutics International, Ltd. ... Lundbeck is a global pharmaceutical company specializing in brain ...

seekingalpha.com/article/2240923-chelsea-therapeutics-going-private-transaction-provides-significant-upside

Chelsea Therapeutics currently trades slightly above the cash consideration of the ... CHTP investors will be receiving $6.44/share in cash (vs. current price of ...

topics.nytimes.com/top/news/business/companies/chelsea-therapeutics-international-ltd/index.html

Chelsea Therapeutics International Ltd. financial and business news, updates, and information from The New York Times and other leading providers.